Fetus or newborn affected by fetal blood sampling (Q46002): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Knowledge Architect | |||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||
Normal rank | |||
Revision as of 14:18, 13 August 2026
Fetal blood sampling involves extracting a sample of fetal blood from the umbilical cord using a needle and an ultrasound as a guide. It is used to detect fetal abnormalities and is generally performed after the completion of 18 weeks of gestation. Risks to the fetus and newborn include: miscarriage, bleeding from the needle entry site, uterine infection and temporary slowing of the baby’s heart rate following the procedure.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | KD39.2 |
||
| English | Fetus or newborn affected by fetal blood sampling |
Fetal blood sampling involves extracting a sample of fetal blood from the umbilical cord using a needle and an ultrasound as a guide. It is used to detect fetal abnormalities and is generally performed after the completion of 18 weeks of gestation. Risks to the fetus and newborn include: miscarriage, bleeding from the needle entry site, uterine infection and temporary slowing of the baby’s heart rate following the procedure. |
Statements
CID11:KD39.2
0 references
dki-india-KD39.2
0 references
Concluído
0 references
